Search Results - "Ruether DF"

Safety and antibody response to inactivated COVID‐19 vaccine in patients with chronic hepatitis B virus infection.

Authors: He, Taiyu Zhou, Yingzhi Xu, Pan et al.

Source: Liver International. Jun2022, Vol. 42 Issue 6, p1287-1296. 10p. 3 Charts, 2 Graphs.

Coordinated cellular and humoral immune responses after two‐dose SARS‐CoV2 mRNA vaccination in liver transplant recipients.

Authors: D'Offizi, Gianpiero Agrati, Chiara Visco‐Comandini, Ubaldo et al.

Source: Liver International. Jan2022, Vol. 42 Issue 1, p180-186. 7p. 1 Chart, 1 Graph.

T- and B-cell immune response to COVID vaccination in liver transplant recipients based on interferon-gamma release assay and serum antibody levels.

Authors: DinuAbirami, Premkumar Panneerselvam, Sugan Mouleeswaran, K et al.

Source: Gastroenterology, Hepatology & Endoscopy Practice. Oct-Dec2023, Vol. 3 Issue 4, p153-158. 6p.

Meta-analysis of the immunogenicity of standard and booster SARS-CoV-2 vaccination in patients with chronic liver disease and post-liver transplantation.

Authors: Wen-Xin Wang Jitao Wang Rui Jia et al.

Source: Portal Hypertension & Cirrhosis. Jun2023, Vol. 2 Issue 2, p61-77. 17p.

Analysis of the humoral and cellular response after the thirdCOVID‐19 vaccination in patients with autoimmune hepatitis.

Authors: Hartl, Johannes Rüther, Darius Ferenc Duengelhoef, Paul Maria et al.

Source: Liver International. Feb2023, Vol. 43 Issue 2, p393-400. 8p. 3 Charts, 2 Graphs.

Efficacy, immunogenicity, and safety of COVID-19 vaccines in individuals with liver cirrhosis: a rapid review and meta-analysis.

Authors: Salajegheh, Faranak Zadeh Rukerd, Mohammad Rezaei Nakhaie, Mohsen et al.

Source: Clinical & Experimental Vaccine Research. Apr2024, Vol. 13 Issue 2, p83-90. 8p.

Sars‐Cov‐2 vaccination in liver transplant recipients: The 'holy grail' in a hostile environment.

Authors: Burra, Patrizia Russo, Francesco Paolo

Source: Liver International. Jun2022, Vol. 42 Issue 6, p1225-1228. 4p. 1 Chart.

COVID-19 vaccines in patients with decompensated cirrhosis: a retrospective cohort on safety data and risk factors associated with unvaccinated status.

Authors: Cao, Zhujun Zhang, Chenxi Zhao, Shuang et al.

Source: Infectious Diseases of Poverty. 5/16/2022, Vol. 11 Issue 1, p1-9. 9p.

Study protocol: combined N-of-1 trials to assess open-label placebo treatment for antidepressant discontinuation symptoms [FAB-study].

Authors: Müller, Amke Konigorski, Stefan Meißner, Carina et al.

Source: BMC Psychiatry. 10/13/2023, Vol. 23 Issue 1, p1-13. 13p.

COVID-19 vaccine immunogenicity in Mongolian adults with and without chronic hepatitis.

Authors: Callier V Jargalsaikhan G Batkhuu M et al.

Source: BMC infectious diseases [BMC Infect Dis] 2026 Mar 24; Vol. 26 (1). Date of Electronic Publication: 2026 Mar 24.

Publication Type: Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334 (Electronic) Linking ISSN: 14712334 NLM ISO Abbreviation: BMC Infect Dis Subsets: MEDLINE

Immunogenicity and safety of a third dose of anti‐SARS‐CoV‐2 BNT16b2 vaccine in liver transplant recipients.

Authors: Toniutto, Pierluigi Cussigh, Annarosa Cmet, Sara et al.

Source: Liver International. Feb2023, Vol. 43 Issue 2, p452-461. 10p. 4 Charts, 4 Graphs.

Immunogenicity of COVID‐19 vaccines in chronic liver disease patients and liver transplant recipients: A systematic review and meta‐analysis.

Authors: Luo, De Chen, Xinpei Du, Juan et al.

Source: Liver International. Jan2023, Vol. 43 Issue 1, p34-48. 15p. 1 Diagram, 6 Charts, 4 Graphs.

Humoral and cellular response of COVID‐19 vaccine among solid organ transplant recipients: A systematic review and meta‐analysis.

Authors: Meshram, Hari Shankar Kute, Vivek Rane, Hemant et al.

Source: Transplant Infectious Disease. Dec2022, Vol. 24 Issue 6, p1-14. 14p.

High‐resolution analysis of individual spike peptide‐specific CD4⁺ T‐cell responses in vaccine recipients and COVID‐19 patients.

Authors: Karsten, Hendrik Cords, Leon Westphal, Tim et al.

Source: Clinical & Translational Immunology. 2022, Vol. 11 Issue 8, p1-23. 23p.

Mycophenolate mofetil decreases humoral responses to three doses of SARS‐CoV‐2 vaccine in liver transplant recipients.

Authors: Meunier, Lucy Sanavio, Mathilde Dumortier, Jérôme et al.

Source: Liver International. Aug2022, Vol. 42 Issue 8, p1872-1878. 7p. 1 Color Photograph, 1 Diagram, 3 Charts.

Evaluation of SARS-CoV-2 anti-Spike antibody levels and breakthrough infection risk among vaccinated adults in North Lebanon.

Authors: Nour, Dalal Ismail, Mohamad Bachar Osman, Marwan et al.

Source: PLoS ONE. 5/9/2024, Vol. 19 Issue 5, p1-16. 16p.

Impact of COVID-19 vaccination on liver transplant recipients. Experience in a reference center in Mexico.

Authors: Azamar-Llamas, Daniel Arenas-Martinez, Josealberto Sebastiano Olivas-Martinez, Antonio et al.

Source: PLoS ONE. 3/28/2024, Vol. 19 Issue 3, p1-11. 11p.

COVID-19 in Individuals with Chronic Liver Diseases.

Authors: Toutoudaki, Konstantina Androutsakos, Theodoros

Source: Journal of Gastrointestinal & Liver Diseases. Mar2024, Vol. 33 Issue 1, p7-10. 4p.

Type 1 interferon auto-antibodies are elevated in patients with decompensated liver cirrhosis.

Authors: Greville, Gordon Cremen, Sinead O'Neill, Shauna et al.

Source: Clinical & Experimental Immunology. Feb2024, Vol. 215 Issue 2, p177-189. 13p.

Proposal of Stroop test cut‐off values as screening for neuropsychological impairments in cirrhosis: A Japanese multicenter study.

Authors: Kondo, Yasuteru Iwasa, Motoh Kawaratani, Hideto et al.

Source: Hepatology Research. Jun2021, Vol. 51 Issue 6, p674-681. 8p.